Leptinemia is not a risk factor for ischemic heart disease in men: Prospective results from the Quebec Cardiovascular Study

Diabetes Care

Volumn 21, Issue 5, 1998, Pages 782-786

  Couillard, Charles ^a   Lamarche, Benoit ^a   Mauriége, Pascale ^a   Cantin, Bernard ^a   Dagenais, Gilles R ^b   Moorjanl, Sltal ^a   Lupien, Paul J ^a   Després, Jean Pierre ^a,c  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Université Laval   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ADULT; AGED; ARTICLE; BODY FAT; CANADA; CONTROLLED STUDY; CORONARY RISK; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN BLOOD LEVEL; RISK FACTOR;

AGED; APOLIPOPROTEINS B; BODY MASS INDEX; CANADA; CASE-CONTROL STUDIES; CHOLESTEROL; COHORT STUDIES; FASTING; FOLLOW-UP STUDIES; FRANCE; HUMANS; INSULIN; LEPTIN; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; PROTEINS; RISK FACTORS; TRIGLYCERIDES;

EID: 0031735742     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.5.782     Document Type: Article

References (26)

1. Kissebah AH, Krakower GR: Regional adiposity and morbidity. Physiol Rev 74:761-811, 1994
2. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994
3. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodents: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1:1155-1161, 1995
4. Hamilton BS, Paglia D, Kwan AYM, Deitel M: Increased obese mRNA expression in omental fat cells from massively obese humans. Nature Med 1:953-956, 1995
5. Klein S, Coppack SW, Mohamed-Ali V, Landt M: Adipose tissue leptin productior and plasma leptin kinetics in humans. Diabetes 45:984-987, 1996
6. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M: Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 45:695-698, 1996
7. Haffner SM, Stem MF, Miettinen H, Wei M, Gingerich RL: Leptin concentrations in diabetic and nondiabetic Mexican-Americans Diabetes 45:822-824, 1996
8. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP: Serum immunoreactive-leptir concentrations in normal-weight and obese subjects. N Engl J Med 334:292-295, 1996
9. Vidal H, Auboeuf D, DeVos P, Staels B, Riou JP, Auwerx J, Laville M: The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcuta neous adipose tissue, J Clin Invest 98:251-255, 1995
10. Segal KR, Landt M, Klein S: Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 45:988-991, 1996
11. Lönnqvist F, Arner P, Nordfors L, Schalling M: Overexpression of the obese (OB) gene in adipose tissue of human obese subjects. Nature Med 1:950-953, 1995
12. Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mon K, Tamura N, Hosoda K, Yoshimasa Y, Jingami H, Kawada T, Nakao K: Human obese gene expression: adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 44:855-858, 1995
13. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B: The ob gene and insulin: a relationship leading to clues to the understanding of obesity. Diabetes. 44:1467-1470, 1995
14. Leroy P, Dessolin S, Villageois P, Moon BC Friedman JM, Ailhaud G, Dani C: Expression of ob gene in adipose cells: regulatior by insulin. J Biol Chem 271:2365-2368, 1996
15. Dagenais GR, Robitaille NM, Lupien PJ, Christen A, Gingras S, Moorjani S, Meyer F, Rochon J: First coronary heart disease event rates in relation to major risk factors: Québec Cardiovascular Study. Can J Cardiol 6:274-280, 1990
16. Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N EngI J Med 334:952-957, 1996
17. Lamarche B, Després JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ: Prevalence of dyslipidemic phenotypes in ischémic heart disease. Am J Cardiol 75:1189-1195, 1995
18. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE: International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 108:150-158, 1984
19. Moorjani S, Dupont A, Labrie F: Increase in plasma high density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism 36:244-250, 1987
20. 2 precipitation procedures for estimating cholesterol in high-density lipoproteins. Clin Chem 24: 323-338, 1978
21. Laurell CB: Electroimmunoassay Scand J Clin Lob Med 124:23-27, 1972
22. Morgan CR, Lazarow A: Immunoassay of insulin: two antibody system: plasma insulin levels in normal, subdiabetic and diabetic rats. Diabetes 12:115-126, 1963
23. Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR, Després JP: Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec Cardiovascular Study. Circulation 94:273-278, 1996
24. Roche AF, Chumlea WMC: New approaches to the clinical assessment of adipose tissue. In Obesity. Bjorntorp P, Brodoff BM, Eds. Philadelphia, JB Lippincott, 1992, p. 55-66
25. Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C: Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 10:497-511, 1990
26. 26. Lemieux S, Després JP: Metabolic complications of visceral obesity: contribution to the etiology of type 2 diabetes and implications for prevention and treatment. Diabete Metab 20:375-393, 1994